Evidence map›Paper›PMID 26836515›Full record

ArticleJournal of cognitive neuroscience2016

Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease.

Nelleke C van Wouwe, Kristen E Kanoff, Daniel O Claassen, Charis A Spears, Joseph Neimat, Wery P M van den Wildenberg, Scott A Wylie

Registry-linked trialAbstract read
In one paragraph

Article in Journal of cognitive neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03665493 (Dopamine Effect on Inhibitory Control), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03665493 nacompletednot on this mapstarted 2020, after this paper: background citation

Dopamine Effect on Inhibitory Control

TypeinterventionalSponsorGiovanni MirabellaRan2020 to 2023Enrolled90ConditionsIdiopathic Parkinson's DiseaseArmsPD patients H&Y=1.5-2 Medications ON, PD patients H&Y=1.5-2 Medications OFF, Healthy age-matched controls, PD patients H&Y=3 Medications OFF, PD patients H&Y=3 Medications ON
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's disease.Cortex; a journal devoted to the study of the nervous system and behavior · 2019
    Article
  14. Article
  15. ELF: A new measure of response capture.Psychonomic bulletin & review · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nelleke C van WouweVanderbilt University Medical Center.
Kristen E KanoffVanderbilt University Medical Center.
Daniel O ClaassenVanderbilt University Medical Center.
Charis A SpearsVanderbilt University Medical Center.
Joseph NeimatVanderbilt University Medical Center.
Wery P M van den WildenbergUniversity of Amsterdam.
Scott A WylieVanderbilt University Medical Center.

Funding

Dopamine Effects on Mesocorticolimbic Function in Parkinson DiseaseK23NS080988 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CLAASSEN, DANIEL OLIVER · 2013 to 2017
$904k
Neurocognitive Mechanisms of Inhibition Deficits in Parkinson's DiseaseK23AG028750 · NIA · VANDERBILT UNIVERSITY · PI WYLIE, SCOTT A · 2009 to 2013
$791k
The Impact of Deep Brain Stimulation on Frontal-Subcortical Emotional ProcessingR21NS070136 · NINDS · VANDERBILT UNIVERSITY · PI FOLLEY, BRADLEY SCOTT, NEIMAT, JOSEPH S · 2011 to 2012
$423k
NIA NIH HHS K23 AG028750NIA NIH HHS K23AG028750NINDS NIH HHS K23 NS080988NINDS NIH HHS R21 NS070136
6 · The paper itself

Abstract

Dopamine plays a key role in a range of action control processes. Here, we investigate how dopamine depletion caused by Parkinson disease (PD) and how dopamine restoring medication modulate the expression and suppression of unintended action impulses. Fifty-five PD patients and 56 healthy controls (HCs) performed an action control task (Simon task). PD patients completed the task twice, once withdrawn from dopamine medications and once while taking their medications. PD patients experienced similar susceptibility to making fast errors in conflict trials as HCs, but PD patients were less proficient compared with HCs at suppressing incorrect responses. Administration of dopaminergic medications had no effect on impulsive error rates but significantly improved the proficiency of inhibitory control in PD patients. We found no evidence that dopamine precursors and agonists affected action control in PD differently. Additionally, there was no clear evidence that individual differences in baseline action control (off dopamine medications) differentially responded to dopamine medications (i.e., no evidence for an inverted U-shaped performance curve). Together, these results indicate that dopamine depletion and restoration therapies directly modulate the reactive inhibitory control processes engaged to suppress interference from the spontaneously activated response impulses but exert no effect on an individual's susceptibility to act on impulses.

Indexed as

Reactive InhibitionAgedDopamine AgonistsFemaleHumansImpulsive BehaviorIndividualityMaleMiddle AgedNeuropsychological TestsParkinson DiseasePhotic StimulationPsychomotor PerformanceReaction TimeVisual PerceptionDopamine Agonists

Identifiers

PMID26836515
PMCPMC4896305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.